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Abstract
Magnesium is essential for bone stability, neuronal excitability, muscular relaxation and many other
metabolic functions. Despite its fundamental biological importance, mechanisms controlling systemic
magnesium homeostasis are only partially understood. The kidney plays a central role in maintaining
magnesium balance as evident from several rare inherited disorders of renal magnesium transport.
Recent studies shed new light on molecular mechanisms of renal magnesium handling and its control.
Mutations in the claudin 16 (paracellin) paracellular protein in the thick ascending limb (TAL) of
Henle's loop and in the transient receptor potential cation channel, subfamily 6, member 6 (TRPM6)
magnesium channel expressed in distal tubules found in patients with renal magnesium wasting and
hypomagnesemia underscore the importance of these transport proteins. A study by Hou et al (J Biol
Chem 2007; 282: 17114-22) demonstrates a pathomechanism for claudin 16 mutations that gives
interesting insights into the function of the TAL. Moreover, Groenestege and colleagues report (J Clin
Invest 2007; 117: 2260-7) the identification of the epidermal growth factor (EGF) as a hormonal
regulator of TRPM6 activity, and thereby explain how mutations in EGF can cause familial
hypomagnesemia. Interestingly, cetuximab, a drug used in treatment of certain cancers, acts an inhibitor
of the EGF receptor and causes hypomagnesemia which may be due to the inhibition of EGF signaling.
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ABSTRACT
Magnesium is essential for bone stability, neuronal exci-
tability, muscular relaxation and many other metabolic
functions. Despite its fundamental biological importance,
mechanisms controlling systemic magnesium homeosta-
sis are only partially understood. The kidney plays a cen-
tral role in maintaining magnesium balance as evident
from several rare inherited disorders of renal magnesium
transport. Recent studies shed new light on molecular
mechanisms of renal magnesium handling and its con-
trol. Mutations in the claudin 16 (paracellin) paracellular
protein in the thick ascending limb (TAL) of Henle’s loop
and in the transient receptor potential cation channel,
subfamily 6, member 6 (TRPM6) magnesium channel ex-
pressed in distal tubules found in patients with renal ma-
gnesium wasting and hypomagnesemia underscore the
importance of these transport proteins. A study by Hou
et al (J Biol Chem 2007; 282: 17114-22) demonstrates a
pathomechanism for claudin 16 mutations that gives in-
teresting insights into the function of the TAL. Moreover,
Groenestege and colleagues report (J Clin Invest 2007;
117: 2260-7) the identification of the epidermal growth
factor (EGF) as a hormonal regulator of TRPM6 activity,
and thereby explain how mutations in EGF can cause fa-
milial hypomagnesemia. Interestingly, cetuximab, a drug
used in treatment of certain cancers, acts an inhibitor of
the EGF receptor and causes hypomagnesemia which
may be due to the inhibition of EGF signaling.
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RENAL MAGNESIUM HANDLING
Magnesium is an essential mineral important for bone stabili-
ty, muscular relaxation, neurotransmission, enzymatic reac-
tions and many other body and cell functions (for reviews,
see (1, 2)). Consequently, states of magnesium deficiency
cause tetany, cardiac arrhythmia, decreased bone stability,
increased susceptibility to epileptic seizures in children and
higher incidence of renal kidney stones. Accordingly, magne-
sium homeostasis is tightly controlled and the product of reg-
ulated intestinal absorption from diet, controlled deposition
and distribution in the body and highly adapted renal excre-
tion or reabsorption. However, despite the biological impor-
tance of magnesium, molecular mechanisms of intestinal
magnesium uptake and renal reabsorption as well as their
regulation have been widely elusive due to our lack of knowl-
edge regarding the molecules involved. Our knowledge of
epithelial magnesium handling stems mainly from the study of
rare inherited human conditions that cause hypomagnesemia
and renal magnesium wasting (3). Magnesium, as with most
small ions, is freely filtered in the glomerulus, and only a small
fraction is reabsorbed in the proximal tubule. The majority of
magnesium is reabsorbed in the thick ascending limb (TAL) of
Henle’s loop via paracellular pathways and in the distal tubule
via transcellular pathways. Over the last few years 4 mole-
cules have been identified that play an important role in renal
and to some extent intestinal magnesium transport. The first
molecule identified was a so-called gamma subunit of the
Na+,K+-ATPase pump belonging to the FXYD proteins of reg-
ulatory subunits of this important pump (4). However, the
mechanism by which mutations in this subunit cause renal
magnesium wasting has not been determined yet. The dis-
covery of claudin 16 (paracellin) as mutated in patients with
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the rare syndrome of familial hypomagnesemia with
hypercalciuria and nephrocalcinosis (FHHNC), in 1999 by
the laboratory of R. Lifton, was a landmark in our under-
standing of the role of claudins in general and the mecha-
nisms of renal magnesium handling as discussed below
(5). A recent study by Hou et al (6) explains at least in part
how claudin 16 may be involved in renal magnesium reab-
sorption and offers as well interesting insights into the
function of the TAL (see below) (Fig. 1). A third important
player in renal magnesium handling was identified in
another familial disorder of renal magnesium handling,
hypomagnesemia with secondary hypocalcemia, which is
due to mutations in the transient receptor potential cation
channel, subfamily 6, member 6 (TRPM6) expressed in the
distal convoluted tubule. TRPM6 associates with a highly
homologous protein, TRPM7, which may form heteromer-
ic ion channels (3, 8, 9). Both proteins may also play a
major role in intestinal magnesium absorption as dis-
cussed later. More interestingly, a novel study by
Groenestege et al, published in the August issue of the
Journal of Clinical Investigation, describes the first hor-
monal regulator of renal magnesium handling, the epider-
mal growth factor (EGF) stimulating TRPM6 activity (7). 
Our textbook knowledge of the TAL implies that this seg-
ment is made of a very tight epithelium which is important
for reabsorbing salt and thereby generating a high intersti-
tial medullary osmolarity allowing for water reabsorption in
the collecting duct. Salt absorption occurs via the apical
electroneutral Na+-K+-2Cl- cotransporter NKCC2, the mol-
ecular target of loop diuretics. Potassium is shunted back
into urine via renal outer medullary potassium channels
(ROMKs) and is therefore involved in generating and main-
taining a lumen-positive potential which in turn drives
paracellular magnesium and calcium absorption. The dis-
covery of the paracellular protein claudin 16 expressed in
the tight junctions of the TAL and its involvement in TAL
magnesium reabsorption, first suggested that claudin 16
was a paracellular pathway for magnesium. This view has
been considerably challenged by several studies.
Kausalya et al investigated a series of claudin 16 muta-
tions found in patients by expressing them in renal cell
lines and reported that most of these mutant proteins
were retained intracellularly. A few mutants were routed
normally to the tight junctions and displayed reduced
magnesium conductivity (10). However, other studies
demonstrated that claudin 16 has only a low permeability
for magnesium but a much higher permeability for sodi-
um, and proposed that claudin 16 may form a paracellular
shunt for sodium from interstitium to lumen thereby con-
tributing to the lumen positive potential (11). This hypothe-
sis was further evaluated in a recent elegant study by Hou
et al using RNA interference technology to generate a
mouse model with highly reduced claudin 16 expression
(6). This mouse model displayed magnesuria and calci-
uria, loss of bone mass and subsequent development
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Fig. 1 - Mechanisms of magnesium reabsorption in the kid-
ney. Some magnesium is reabsorbed in the proximal tubule,
however, the thick ascending limb (TAL) and distal convolu-
ted tubule (DCT) are major sites of regulated magnesium
absorption. The lower scheme depicts a typical TAL cell
where the apical Na+-K+-2Cl- cotransporter NKCC2 is
responsible for sodium absorption. As indicated by the new
findings of Hou et al (6), sodium partially leaks back into the
lumen via claudin 16, generates a lumen positive potential
(PD), and thereby drives magnesium and calcium absorption
through the paracellular pathway. In the DCT (upper sche-
me), magnesium is absorbed by the TRPM6 channel; the
molecular identity of other pathways is currently unknown.
Groenestege et al describe how the pro-EGF expressed on
the basolateral membrane is cleaved to yield EGF engaging
the EGF receptor (EGFR) which in turn stimulates TRPM6
activity (7). 
nephrocalcinosis as seen in patients with familial hypo-
magnesemia with hypercalciuria and nephrocalcinosis. A
more detailed analysis of TAL function revealed that the
paracellular sodium permeability was decreased and the
lumen positive potential strongly reduced in mice lacking
claudin 16. Taken together with the in vitro data demon-
strating a high sodium permeability of claudin 16, this
draws a new picture of the role of claudin 16 in TAL func-
tion. It appears that claudin 16 may be part of the tight
junction complex that selectively mediates sodium back-
leak into the TAL lumen and generation of the lumen posi-
tive potential which is critical for paracellular magnesium
and calcium reabsorption. However, the molecular identity
of the tight junction proteins that mediate the selective
magnesium and calcium reabsorption remains to be
uncovered. These findings also shed new light on our
textbook knowledge of the TAL as a tight epithelium which
may not be so tight after all.
The distal convoluted tubule (DCT) is the site of regulated
fine-tuning of renal magnesium reabsorption from urine or
excretion into urine, respectively. Magnesium enters the
DCT cells along its electrochemical gradient through
TRPM6 channels. Intracellular magnesium buffering and
transport to and across the basolateral membrane has not
been elucidated on a molecular level to this date. Even
though it is known that many factors including dietary
magnesium intake, sex hormones or acid-base status
influence renal magnesium handling, no magnesiotropic
hormone has been identified (1, 3). Studying a family with
a form of autosomal recessive renal hypomagnesemia,
Groenestege and colleagues (7) excluded all known genes
affected in disorders of renal magnesium transport.
Subsequent linkage analysis and sequencing identified
mutations in the pro-EGF gene (precursor of the epidermal
growth factor), a membrane-bound protein that can be
released after cleavage into extracellular space. EGF is
highly abundant in the DCT and appears to be secreted
both on the apical and basolateral side, whereas the
receptors for EGF (EGFR) are mainly found on the basolat-
eral membrane. The mutations in pro-EGF appear to
affect basolateral sorting and secretion of EGF, whereas
apical release is not affected. The authors then went on to
demonstrate that EGF stimulates TRPM6 activity in trans-
fected cells. Cetuximab is a monoclonal antibody prepara-
tion that represents a novel treatment for colorectal can-
cer and acts via inhibition of the EGF receptor. Cetuximab
blocked in vitro EGF-dependent stimulation of TRPM6
channel activity and caused in patients a clear hypomag-
nesemia and renal magnesium wasting. Taken together,
this publication establishes EGF as an autocrine and
paracrine regulator of renal magnesium reabsorption and
identifies the first magnesiotropic hormone. However, it
remains to be clarified how EGF release and signaling is
coordinated with whole body homeostasis and if EGF
itself is regulated by other magnesium sensors. Also, clari-
fication of the role of EGF in intestinal magnesium absorp-
tion will be interesting.
Both studies advance our knowledge of how magnesium
homeostasis is achieved and which renal mechanisms are
involved in the transport of magnesium and its control.
However, our overall picture remains incomplete as long
as we do not know anything of the major proteins that are
predicted to be involved in intracellular magnesium buffer-
ing and shuttling, that mediate basolateral transport or
that contribute to the regulation of systemic magnesium
balance. The study of rare inherited disorders of (renal)
magnesium transport has helped to identify most molecu-
lar mechanisms know to date. Clinical characterization of
patients with inherited forms of renal hypomagnesemia
may help to isolate more families with novel gene defects
and elucidate basic principles controlling this important
electrolyte. 
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